RT Journal Article
SR Electronic
T1 Modelling the impact of COVID-19-related control programme interruptions on progress towards the WHO 2030 target for soil-transmitted helminths
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.01.20220376
DO 10.1101/2020.11.01.20220376
A1 Veronica Malizia
A1 Federica Giardina
A1 Carolin Vegvari
A1 Sumali Bajaj
A1 Kevin McRae-McKee
A1 Roy M Anderson
A1 Sake J de Vlas
A1 Luc E Coffeng
YR 2020
UL http://medrxiv.org/content/early/2020/11/04/2020.11.01.20220376.abstract
AB Background On the 1st of April 2020, the World Health Organization (WHO) recommended an interruption of all neglected tropical disease control programmes, including soil-transmitted helminths (STH), in response to the COVID-19 pandemic. This paper investigates the impact of this disruption on the achieved progress towards the WHO 2030 target for STH.Methods We used two stochastic individual-based models to simulate the impact of missing one or more preventive chemotherapy (PC) rounds in different endemicity settings. We also investigate the extent to which the impact can be lessened by mitigation strategies, such as semi-annual or community-wide PC.Results Both models show that even without a mitigation strategy, control programmes will catch up by 2030. The catch-up time is limited to a maximum of 4.5 years after the interruption. Mitigations strategies may reduce this catch-up time by up to two years and can even increase the probability of achieving the 2030 target.Conclusions Though a PC interruption will only temporarily impact the progress towards the WHO 2030 target, programmes are encouraged to restart as soon as possible to minimise the impact on morbidity. The implementation of suitable mitigation strategies can turn the interruption into an opportunity to accelerate the progress toward reaching the target.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work was supported by the Bill and Melinda Gates Foundation in partnership with the Task Force for Global Health through the NTD Modelling Consortium [OPP105116 and OPP108566]. LEC further acknowledges funding from the Dutch Society for Scientific Research [NWO, grant 016.Veni.178.023]. FG acknowledges funding from a European Marie Sklodowska-Curie fellowship [H2020-COFUND-2015-FP-707404]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe simulations results of this article are available from the corresponding author on request.